Bramox 5 Mg Tablets
Mr 210 mm ■>1
Package leaflet: Information for the user
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
KEEP THIS LEAFLET. YOU MAY NEED TO READ IT AGAIN.
If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others.
It may harm them, even if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet See section 4.
1 What Bramox tablets are and what they are used for
2 What you need to know before you take Bramox tablets
3 How to take Bramox tablets
4 Possible side effects
5 How to store Bramox tablets
6 Contents of the pack and other information
^ What Bramox tablets are and what they are used for
The name of your medicine is Bramox tablets. They contain the medicine midodrine hydrochloride. This belongs to a group of medicines called adrenergic and dopaminergic agents. Midodrine hydrochloride is a medicine that raises your blood pressure and is used to treat certain severe forms of low blood pressure in adults when other treatments have not worked.
^ What you need to know before you take Bramox tablets
DO NOT TAKE BRAMOX TABLETS IF:
• you are allergic to midodrine hydrochloride or any of the other ingredients of this medicine (listed in section 6 of this leaflet)
• you have high blood pressure
• you have a slow pulse
• you have difficulty urinating
• you have certain forms of cardiovascular disease
• you have elevated pressure in the eye (glaucoma) or poor vision as a result of diabetes
• you have an overactive thyroid gland
• you have hormonal disorders caused by a tumour in the adrenal medulla (pheochromocytoma)
• you have severe kidney disease
• you have an enlarged prostate Warnings and precautions
Talk to your doctor or pharmacist before taking this medicine if you have been told you have high blood pressure when you lie down.
If this applies to you then:
Regular monitoring of your blood pressure when you are lying down and when you are standing up will be required as there may be a risk of your blood pressure rising when you lie down, for example, at night If your blood pressure does go up when you lie down and reducing the dose does not correct this problem, then treatment with this medicine must be stopped.
It is important that you do not take this medicine late in the evening.
Take your last daily dose at least 4 hours before you go to bed.
By keeping your head elevated at night the potential risk of your blood pressure rising when you lie down is reduced.
You should be monitored by your doctor for possible secondary effects of high blood pressure.
Also talk to your doctor if you:
• have a serious disorder of the nervous system (autonomic nervous system disorders), since taking this medicine may lead to a further drop in blood pressure when you stand up. If this occurs, further treatment with this medicine should be stopped.
• suffer from problems with your circulation.
• suffer from a disease of the prostate, as you may find passing urine is difficult when taking this medicine.
You should have your kidney function and blood pressure checked by your doctor before you start using this medicine. During treatment with this medicine, your blood pressure will be checked from time to time, and if necessary your dose adjusted.
It is important that you immediately report symptoms related to high blood pressure, such as elevated heart rate, headache and blurred vision. Your doctor will then decide whether to adjust dosage or discontinue your treatment with Bramox tablets.
If any of the warnings apply to you, or have in the past, talk to your doctor. Children and adolescents
Do not give this medicine to children and adolescents under the age 18 because the safety and efficacy of Bramox tablets in this age group have not been established.
Tell your doctor or pharmacist if you are taking, have recently taken or
might take any other medicines.
IN PARTICULAR, TELL YOUR DOCTOR OR PHARMACIST
IF YOU ARE TAKING ANY OF THE FOLLOWING:
• Reserpine and guanethidine (medicines used to reduce high blood pressure), antihistamines (used to treat allergies), hormones for the thyroid (used when the thyroid is not working properly), tricyclic antidepressants and MAO-inhibitors (both used to treat depression) and other vasoconstrictors (medicines that narrow blood vessels), or sympathomimetic agents (medicines that have a stimulating effect on certain parts of the nervous system) because concomitant use with this medicine may cause a large increase in blood pressure.
• Prazosin and phentolamine (medicines used to treat heart disease) because the effect of this medicine is blocked by these drugs.
• Digitalis preparations (medicines used to treat heart disease) because concomitant use with this medicine may lead to cardiac dysfunction.
• Fludrocortisone acetate (an anti-inflammatory medicine) because this medicine may increase its effect.
• Medicines which directly or indirectly reduce your heart rate because if this medicine is combined with these medicines, it is advisable that your doctor closely monitors you.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Using this medicine while pregnant is not recommended. Tell your doctor if you are pregnant, or want to be, while you are being treated with this medicine.
Do not use this medicine while breast-feeding.
This medicine should not affect your ability to drive or use machines. However, you must be careful if dizziness or light-headedness occurs after taking this medicine.
Sunset Yellow FCF can cause allergic reactions.
^ How to take Bramox tablets
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Swallow tablets with a drink of water. This medicine may be taken with or without food.
The scoreline is only to facilitate breaking for ease of swallowing and not to divide into equal doses.
Your doctor will decide your dose and tell you how long you should take this medicine. The treatment is usually long-term.
The recommended starting dose is normally one tablet of 2.5 mg three times a day. This dose can be increased weekly up to four 2.5 mg tablets, or two 5 mg tablets (10 mg) three times daily, which is the usual maintenance dose of 30 mg per day. The recommended total daily dose should be spread evenly into three doses per day.
Avoid taking this medicine in the late evening. The last dose should be taken at least 4 hours before your bedtime. Elevating your head at night reduces the potential risk of high blood pressure when you lie down. More information can be found in the section “Warnings and precautions" of this leaflet.
If you feel that the effect of this medicine is too strong, or too weak, talk to your doctor or pharmacist
If you have used too much of this medicine please contact your doctor or pharmacist immediately.
High blood pressure (hypertension), slow heart rate (bradycardia), difficulty urinating, goosebumps, feelings of coldness
If you forget to take a dose, take your next dose as usual and then keep taking your medicine as your doctor has told you. Do not take a double dose to make up for a forgotten dose, because this will increase the risk of high blood pressure when you lie down.
There will be no sudden drop in your blood pressure. Always talk to your doctor if you are considering stopping taking this medicine. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Q Possible side effects
LIKE ALL MEDICINES, BRAMOX TABLETS CAN CAUSE SIDE EFFECTS, ALTHOUGH NOT EVERYBODY GETS THEM.
Common (may affect more than 1 in 100 but less than 1 in 10 people): tingling and itching, increased blood pressure when lying down, headache, nausea (feeling sick), heartburn, inflammation of the lining inside the mouth, flushing, rash, chills, difficulty urinating.
Uncommon (may affect more than 1 in 1,000 but less than 1 in 100 people): sleep disturbances including difficulty sleeping, restlessness, agitation and irritability, slowed heart rate, urge to urinate.
Rare (may affect more than 1 in 10,000 but less than 1 in 1,000 people): palpitations, rapid heartbeat, abnormal liver function including an increase in the number of liver enzymes.
Not known (frequency cannot be estimated from the available data): abdominal pain, being sick (vomiting), diarrhoea, anxiety, feelings of confusion.
If you get any side effects, talk to your doctor or pharmacist This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme (Website: www.mhra.gov.uk/ yellowcard). By reporting side effects you can help provide more information on the safety of this medicine.
^ How to store Bramox tablets
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the outer carton and on the bottle label or blister foil. The expiry date refers to the last day of that month. For bottle packs only: once opened, use within 8 weeks.
Store below 25°C.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. This will help to protect the environment.
WHAT BRAMOX TABLETS CONTAIN:
The active substance is midodrine hydrochloride.
Each tablet contains either 2.5 mg or 5 mg midodrine hydrochloride.
The other ingredients are microcrystalline cellulose, maize starch, magnesium stearate, and silica colloidal anhydrous.
Bramox 5 mg tablets also contain Sunset Yellow FCF (E110).
The 2.5 mg tablets are white, round tablets marked on one side with “MID” above the score line and “2.5" below the score line.
The 5 mg tablets are orange, round tablets marked on one side with “MID” above the score line and “5" below the score line.
This medicine is available in plastic bottles containing 100 tablets or cartons of 100 tablets in aluminium/aluminium blister packs.
Marketing Authorisation Holder
Brancaster Pharma Limited, Church House, 48 Church Street, Reigate, Surrey RH2 0SN, United Kingdom.
Cross Vetpharm Group UK Limited, Unit 2, Bryn Cefni, Llangefni, Anglesey LL77 7XA, United Kingdom.
This medicinal product is authorised in the Member States of the EEA under the following names:
Netherlands: Midodrine HCI Brancaster 2,5 mg tabletten and Midodrine HCI Brancaster 5 mg tabletten
UK: Bramox 2.5 mg tablets and Bramox 5 mg tablets
Detailed information on this medicine is available on the Medicines and Healthcare Products Regulatory Agency (MHRA) website: http://www.mhra.gov.uk
Very common (may affect more than 1 in 10 people): goosebumps, itching of the scalp and pain when urinating.
This leaflet was last revised in 03-2016